NEXGEL to Report Second Quarter 2024 Financial Results on August 14th
Rhea-AI Summary
NEXGEL (NASDAQ: NXGL), a provider of medical and OTC products specializing in ultra-gentle, high-water-content hydrogels, has announced its plans to report second quarter 2024 financial results on August 14, 2024, after market close. The company will host a conference call at 4:30 P.M. ET on the same day to discuss the results.
Interested parties can join the call via phone at +1-800-579-2543 (U.S. Toll Free) or +1-785-424-1789 (International). A webcast will also be available. For those unable to attend, a replay will be accessible until August 28, 2024, by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) with the code 11156720. An archived version of the webcast will be available for 90 days.
Positive
- None.
Negative
- None.
Management will host a conference call at 4:30 P.M. ET on the same day
LANGHORNE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it will report its financial results for the second quarter 2024, after the market closes on August 14, 2024. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.
Second Quarter 2024 Financial Results Conference Call
Date: August 14, 2024
Time: 4:30 P.M. ET
Live Call: + 1-800-579-2543 (U.S. Toll Free) or + 1-785-424-1789 (International)
Webcast: Events and Presentations
For interested individuals unable to join the conference call, a replay will be available through August 28, 2024 by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11156720. An archived version of the webcast will also be available for 90 days.
About NEXGEL, INC.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Valter@KCSA.com
FAQ
When will NEXGEL (NXGL) report its Q2 2024 financial results?
What time is NEXGEL's Q2 2024 earnings conference call scheduled for?
How can investors access NEXGEL's Q2 2024 earnings call?
Until what date will the replay of NEXGEL's Q2 2024 earnings call be available?
